Over the course of the past ninety days, Reshma Kewalramani has sold $3,565,846.34 in Vertex Pharmaceuticals stock. Most recently, Reshma Kewalramani sold 11,689 shares of the business's stock in a transaction on Monday, August 15th. The shares were sold at an average price of $305.06, for a transaction totalling $3,565,846.34. Following the completion of the sale, the chief executive officer now directly owns 99,598 shares of the company's stock, valued at $30,383,365.88. Learn More on Reshma Kewalramani's trading history.